a Internal Medicine, Gastroenterology and Hepatology , Fondazione Agostino Gemelli Hospital , Rome , Italy.
Expert Rev Gastroenterol Hepatol. 2018 Jul;12(7):641-656. doi: 10.1080/17474124.2018.1481747. Epub 2018 Jun 6.
The gut liver axis is an operative unit that works to protect the human body against potentially harmful substances and microorganisms, maintaining the homeostasis of the immune system. Liver cirrhosis profoundly alters this complex system. The intestine becomes more permeable allowing the translocation of bacteria, bacterial products and fragments into the portal circulation, triggering an abnormal local and systemic inflammatory response and a condition of perpetual immunologic alarm. This immune-inflammatory disorder related to dysbiosis is involved in the development of liver damage and liver cirrhosis complications and increases intestinal permeability in a vicious circle. Areas covered: The most relevant studies on bacterial translocation, the mechanism of intestinal barrier dysfunction and its consequences in patients with liver cirrhosis have been revised through a PubMed search. Data have been discussed with particular regard to their significance in clinical practice. Expert commentary: The assessment of bacterial translocation and intestinal permeability is not currently used in clinical practice but may be useful to stratify patients' prognosis.
肠肝轴是一个作用单位,它可以保护人体免受潜在的有害物质和微生物的侵害,维持免疫系统的内稳态。肝硬化会深刻改变这个复杂的系统。肠道变得更加通透,允许细菌、细菌产物和碎片移位到门静脉循环中,引发异常的局部和全身炎症反应和持续的免疫警报。这种与菌群失调相关的免疫炎症紊乱与肝损伤和肝硬化并发症的发展有关,并在恶性循环中增加肠道通透性。涵盖领域:通过 PubMed 检索,对与细菌易位、肠道屏障功能障碍机制及其在肝硬化患者中的后果相关的最相关研究进行了综述。特别关注了它们在临床实践中的意义。专家评论:细菌易位和肠道通透性的评估目前尚未在临床实践中使用,但可能有助于对患者的预后进行分层。
Expert Rev Gastroenterol Hepatol. 2018-6-6
World J Gastroenterol. 2014-12-7
World J Gastroenterol. 2014-11-14
World J Gastroenterol. 2016-3-14
World J Gastroenterol. 2015-11-7
World J Gastroenterol. 2018-9-14
Hepatol Int. 2017-5-26
World J Gastroenterol. 2015-11-7
Alcohol Clin Exp Res. 2015-5
Gastroenterol Hepatol (N Y). 2025-8
Antibiotics (Basel). 2024-12-4
Clin Exp Med. 2024-9-28
Curr Allergy Asthma Rep. 2024-7